The Medical Technology activities of ZEISS are bundled under the umbrella of the TecDAX-listed company Carl Zeiss Meditec AG. This corporate website provides information on the performance of Carl Zeiss Meditec AG with dedicated investor relations services and services for media professionals.
With headquarters in Jena (Germany) and operating sites and subsidiaries in Germany, France, Spain, the USA and Japan the company has a direct presence in the world in major markets. The company can also exploit the Carl Zeiss group`s powerful global distribution network.
Be informed about the performance, key facts and the shareholder structure.
The Medical Technology Business Group of ZEISS continues to strengthen its leadership team with the appointment of distinguished refractive surgeon and clinical professor of ophthalmology, Steven C. Schallhorn, MD as Chief Medical Officer for Global Ophthalmic Devices. The appointment of Dr. Schallhorn supports ZEISS’ commitment to advancing eye care and helping doctors bring the highest level of clinical care to their patients around the world.
The Medical Technology Business Group of ZEISS announces the introduction in the US of the VisuMax
Revenue, EBIT and earnings per share show positive development